DCT and melanoma: Several studies have previously shown that the expression of melanogenic enzymes (tyrosinase, TRP-1, and TRP-2) is transcriptionally regulated by MITF, resulting in a decrease in melanogenic enzyme expression and the inhibition of melanogenesis in B16F10 melanoma cells [13,14,15,16,17].